Literature DB >> 25530353

Drug-dependent behaviors and nicotinic acetylcholine receptor expressions in Caenorhabditis elegans following chronic nicotine exposure.

Joseph R Polli1, Dorothy L Dobbins1, Robert A Kobet1, Mary A Farwell1, Baohong Zhang1, Myon-Hee Lee2, Xiaoping Pan3.   

Abstract

Nicotine, the major psychoactive compound in tobacco, targets nicotinic acetylcholine receptors (nAChRs) and results in drug dependence. The nematode Caenorhabditis elegans' (C. elegans) genome encodes conserved and extensive nicotinic receptor subunits, representing a useful system to investigate nicotine-induced nAChR expressions in the context of drug dependence. However, the in vivo expression pattern of nAChR genes under chronic nicotine exposure has not been fully investigated. To define the role of nAChR genes involved in nicotine-induced locomotion changes and the development of tolerance to these effects, we characterized the locomotion behavior combining the use of two systems: the Worm Tracker hardware and the WormLab software. Our results indicate that the combined system is an advantageous alternative to define drug-dependent locomotion behavior in C. elegans. Chronic (24-h dosing) nicotine exposure at 6.17 and 61.7μM induced nicotine-dependent behaviors, including drug stimulation, tolerance/adaption, and withdrawal responses. Specifically, the movement speed of naïve worms on nicotine-containing environments was significantly higher than on nicotine-free environments, suggesting locomotion stimulation by nicotine. In contrast, the 24-h 6.17μM nicotine-treated worms exhibited significantly higher speeds on nicotine-free plates than on nicotine-containing plates. Furthermore significantly increased locomotion behavior during nicotine cessation was observed in worms treated with a higher nicotine concentration of 61.7μM. The relatively low locomotion speed of nicotine-treated worms on nicotine-containing environments also indicates adaption/tolerance of worms to nicotine following chronic nicotine exposure. In addition, this study provides useful information regarding the comprehensive in vivo expression profile of the 28 "core" nAChRs following different dosages of chronic nicotine treatments. Eleven genes (lev-1, acr-6, acr-7, acr-11, lev-8, acr-14, acr-16, acr-20, acr-21, ric-3, and unc-29) were significantly up-regulated following 61.7μM nicotine treatment, in which worms showed significantly increased locomotion behavior. This study provides insights into the linkage between nicotine-induced locomotion behavior and the regulation of nicotinic acetylcholine receptors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C. elegans; Drug-dependent behaviors; Gene expression; Nicotine; nAChRs

Mesh:

Substances:

Year:  2014        PMID: 25530353      PMCID: PMC4385460          DOI: 10.1016/j.neuro.2014.12.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  55 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Allosteric receptors after 30 years.

Authors:  J P Changeux; S J Edelstein
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

3.  Concentration- and time-dependent behavioral changes in Caenorhabditis elegans after exposure to nicotine.

Authors:  Robert Sobkowiak; Mateusz Kowalski; Andrzej Lesicki
Journal:  Pharmacol Biochem Behav       Date:  2011-05-23       Impact factor: 3.533

4.  RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.

Authors:  Stuart J Lansdell; Veronica J Gee; Patricia C Harkness; Anne I Doward; Elizabeth R Baker; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2005-08-24       Impact factor: 4.436

5.  Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15.

Authors:  Laurie Sellings; Schreiber Pereira; Cheng Qian; Thomas Dixon-McDougall; Christina Nowak; Bin Zhao; Rachel F Tyndale; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2013-01-25       Impact factor: 3.386

6.  Determination of reliable reference genes for multi-generational gene expression analysis on C. elegans exposed to abused drug nicotine.

Authors:  Faten A Taki; Baohong Zhang
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

7.  alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.

Authors:  V Gerzanich; F Wang; A Kuryatov; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

8.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

9.  An extensive and diverse gene family of nicotinic acetylcholine receptor alpha subunits in Caenorhabditis elegans.

Authors:  N P Mongan; H A Baylis; C Adcock; G R Smith; M S Sansom; D B Sattelle
Journal:  Recept Channels       Date:  1998

10.  The Parallel Worm Tracker: a platform for measuring average speed and drug-induced paralysis in nematodes.

Authors:  Daniel Ramot; Brandon E Johnson; Tommie L Berry; Lucinda Carnell; Miriam B Goodman
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  5 in total

1.  Investigation of feeding behaviour in C. elegans reveals distinct pharmacological and antibacterial effects of nicotine.

Authors:  M M Kudelska; A Lewis; C T Ng; D A Doyle; L Holden-Dye; V M O'Connor; R J Walker
Journal:  Invert Neurosci       Date:  2018-11-07

2.  Exogenous Adenosine Modulates Behaviors and Stress Response in Caenorhabditis elegans.

Authors:  Thayanara Cruz da Silva; Tássia Limana da Silveira; Luiza Venturini Dos Santos; Leticia Priscila Arantes; Rodrigo Pereira Martins; Félix Alexandre Antunes Soares; Cristiane Lenz Dalla Corte
Journal:  Neurochem Res       Date:  2022-08-26       Impact factor: 4.414

3.  The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening.

Authors:  Fudan Zheng; Alan P Robertson; Melanie Abongwa; Edward W Yu; Richard J Martin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-02-10       Impact factor: 4.077

4.  Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress.

Authors:  J Brucker Nourse; Gilad Harshefi; Adi Marom; Abdelrahaman Karmi; Hagit Cohen Ben-Ami; Kim A Caldwell; Guy A Caldwell; Millet Treinin
Journal:  iScience       Date:  2021-02-04

5.  A C. elegans model of electronic cigarette use: Physiological effects of e-liquids in nematodes.

Authors:  Daniel Panitz; Harsha Swamy; Keith Nehrke
Journal:  BMC Pharmacol Toxicol       Date:  2015-12-04       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.